[Short- and long-term treatment results in perianal dermatitis using proctalgen: a controlled prospective study].
In a controlled study the short and long-term therapeutic efficiency and compatibility of Proctalgen was tested in the therapy of perianal dermatitis. The study includes 30 patients of whom 23 had previously been treated with other remedies. After a treatment period of 21 days, 18 patients (60%) were cured. 11 of the 18 cured patients were interviewed three years later and seven of them (64%) were still without any symptoms. None of the patients showed irritations of the rectal mucosa. Proctalgen has proved its short and long-term therapeutic efficiency especially in the treatment of patients with a short history and with no previous therapy and shows a good compatibility. Therefore Proctalgen is an excellent attribute to the therapeutics of perianal dermatitis especially because it is free of corticosteroids and anaesthetics.
Schaub
A
A
Departement Chirurgie, Universitätsspital Zürich.
Buchmann
P
P
D000328:Adult; D000368:Aged; D001004:Anus Diseases / Q000188:drug therapy*; D045424:Complex Mixtures; D003872:Dermatitis / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies
D045424:Complex Mixtures; D003879:Dermatologic Agents; D004338:Drug Combinations; C067736:proctalgen
Kurz- und Langzeitbehandlungsergebnisse der Perianaldermatitis mit Proctalgen: eine kontrollierte prospektive Studie.